Dec 05, 2023 8:00am EST NeoGenomics to Present New Data at San Antonio Breast Cancer Symposium Highlighting Utility of RaDaR for Therapy Response
Nov 14, 2023 7:00am EST NeoGenomics to Participate at the Piper Sandler 35th Annual Healthcare Conference
Oct 24, 2023 7:00am EDT NeoGenomics Announces the Commercial Availability of Two New Tests, Expanding Its Next-Generation Sequencing and Lung Cancer Portfolios
Oct 17, 2023 9:20am EDT NeoGenomics to Report Third Quarter 2023 Financial Results on November 6, 2023